Skip to main content

CORRECTION article

Front. Pharmacol., 08 February 2021
Sec. Drugs Outcomes Research and Policies
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.637775
This article is part of the Research Topic Grand Challenges in Pharmaceutical Medicine: Competencies and Ethics in Medicines Development View all 13 articles

Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

This article is a correction to:

  1. Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

    1. Read original article
Chieko Kurihara Chieko Kurihara1*Varvara BaroutsouVarvara Baroutsou2Sander BeckerSander Becker3Johan BrunJohan Brun4Brigitte Franke-BrayBrigitte Franke-Bray5Roberto CarlesiRoberto Carlesi6Anthony ChanAnthony Chan7Luis Francisco ColliaLuis Francisco Collia8Peter KleistPeter Kleist9Luís Filipe LaranjeiraLuís Filipe Laranjeira10Kotone MatsuyamaKotone Matsuyama11Shehla NaseemShehla Naseem12Johanna SchenkJohanna Schenk13Honorio SilvaHonorio Silva14Sandor Kerpel-FroniusSandor Kerpel-Fronius15 on behalf of Working Group on Ethics of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine
  • 1National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan
  • 2Independent Medical Consultant, and Consultant, Pharmaceutical Medicine, Athens, Greece
  • 3Consultants in Pharmaceutical Medicine, Dover Heights, Australia
  • 4LIF, Stockholm, Sweden
  • 5Independent Consultant, Basel, Switzerland
  • 6Independent Researcher, Bellagio, Italy
  • 7Pfizer Biopharmaceuticals Group, Dublin, Ireland
  • 8Craveri Pharma, Buenos Aires, Argentina
  • 9Cantonal Ethics Committee, Zurich, Switzerland
  • 10Eli Lilly & Co., Lisbon, Portugal
  • 11Nippon Medical School, Tokyo, Japan
  • 12Ferozsons Laboratories Ltd, Karachi, Pakistan
  • 13PPH Plus GmbH & Co. KG, Hochheim am Main, Germany
  • 14IFAPP Academy, New York, NY, United States
  • 15Semmelweis University, Budapest, Hunbary

A corrigendum on
Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

by Kurihara, C., Baroutsou, V., Becker, S., Brun, J., Franke-Bray, B., Carlesi, R., Chan, A., Collia, L. F., Kleist, P., Laranjeira, L. F., Matsuyama, K., Naseem, S., Schenk, J., Silva, H., and Kerpel-Fronius, S. (2020). Front. Pharmacol. 11:579714. doi:10.3389/fphar.2020.579714

In the original article, there were errors.

In the abstract, “(Declaration of Taipei)” was deleted; in the 1 Introduction section, “1948, in its second year” was changed to “in its second and third years”; in the 4 Individual Participant Data (IPD) Sharing and Trial Registration Requirement section, parenthesis before and after “Supplementary Material”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Author Contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of Interest

JB is an employee of LIF; AC is an employee of Pfizer Biopharmaceuticals Group; LC is an employee of Craveri Pharma; LF is an employee of Eli Lilly & Co.; SN is an employee of Ferozsons Laboratories Ltd.; JS is an executive consultant of PPH plus GmbH & Co. KG, Hochheim am Main.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: research ethics, data science, medicines development, privacy protection, data sharing, declaration of Helsinki, declaration of Taipei

Citation: Kurihara C, Baroutsou V, Becker S, Brun J, Franke-Bray B, Carlesi R, Chan A, Collia LF, Kleist P, Laranjeira LF, Matsuyama K, Naseem S, Schenk J, Silva H and Kerpel-Fronius S (2021) Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics. Front. Pharmacol. 11:637775. doi: 10.3389/fphar.2020.637775

Received: 04 December 2020; Accepted: 23 December 2020;
Published: 08 February 2021.

Edited and reviewed by:

Joseph O. Fadare, Ekiti State University, Nigeria

Copyright © 2021 Kurihara, Baroutsou, Becker, Brun, Franke-Bray, Carlesi, Chan, Collia, Kleist, Laranjeira, Matsuyama, Naseem, Schenk, Silva and Kerpel-Fronius. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chieko Kurihara, chieko.kurihara@nifty.ne.jp

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.